StonvexLoading…
StonvexStonvexStonvexCore line items from AGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.93B | $6.06B | $4.32B | $2.39B |
Operating Income | $-463.24M | $-292.13M | $-232.13M | $-105.38M |
Net Income | $-391.35M | $-260.15M | $-262.60M | $-106.55M |
EPS (Diluted) | $-0.98 | $-0.61 | $-0.48 | $-0.22 |
Total Assets | $1.27B | $1.73B | $1.74B | $1.70B |
Total Liabilities | $1.14B | $1.26B | $1.08B | $656.86M |
Cash & Equivalents | $173.71M | $188.23M | $107.57M | $465.30M |
Free Cash Flow OCF − CapEx | $-119.00M | $-71.03M | $-172.03M | $-146.23M |
Shares Outstanding | 414.73M | 412.19M | 406.39M | 412.38M |